These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1963498)

  • 1. The relationship between response to fluoxetine, plasma drug levels, imipramine binding to platelet membranes and whole-blood 5-HT.
    Tyrer SP; Marshall EF; Griffiths HW
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(5):797-805. PubMed ID: 1963498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder.
    Wgner A; Montero D; Mårtensson B; Siwers B; Asberg M
    J Affect Disord; 1990 Oct; 20(2):101-13. PubMed ID: 2176228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipramine binding sites on platelets of patients with major depressive disorder.
    Carstens ME; Engelbrecht AH; Russell VA; Aalbers C; Gagiano CA; Chalton DO; Taljaard JJ
    Psychiatry Res; 1986 Aug; 18(4):333-42. PubMed ID: 3018818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seasonal variation of platelet serotonin uptake and 3H-imipramine binding in normal and depressed subjects.
    Egrise D; Rubinstein M; Schoutens A; Cantraine F; Mendlewicz J
    Biol Psychiatry; 1986 Mar; 21(3):283-92. PubMed ID: 3004612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
    Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
    Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine transport in depression: kinetics and dynamics.
    Healy D; Leonard BE
    J Affect Disord; 1987; 12(2):91-103. PubMed ID: 3036923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma of depressed patients enhances platelet imipramine binding.
    Marazziti D; Rotondo A; Perugi G; Placidi GF; Cassano GB; Pacifici GM
    Biol Psychiatry; 1989 Apr; 25(7):985-7. PubMed ID: 2541806
    [No Abstract]   [Full Text] [Related]  

  • 8. Alteration of platelet [3H]imipramine binding in mildly depressed patients correlates with disease severity.
    Tanimoto K; Maeda K; Terada T
    Biol Psychiatry; 1985 Mar; 20(3):340-3. PubMed ID: 2983789
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential 3H-imipramine platelet binding in patients with panic disorder and depression.
    Innis RB; Charney DS; Heninger GR
    Psychiatry Res; 1987 May; 21(1):33-41. PubMed ID: 3037580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why some depressed patients may have low platelet 3H-imipramine binding.
    Mellerup ET; Plenge P
    Acta Psychiatr Scand; 1990 Oct; 82(4):330-4. PubMed ID: 2175539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet tritiated imipramine binding and serotonin uptake in depressed patients and controls. Relationship to plasma cortisol levels before and after dexamethasone administration.
    Roy A; Everett D; Pickar D; Paul SM
    Arch Gen Psychiatry; 1987 Apr; 44(4):320-7. PubMed ID: 2436589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of [3H]imipramine to human platelet membranes with compensation for saturable binding to filters and its implication for binding studies with brain membranes.
    Phillips OM; Wood KM; Williams DC
    J Neurochem; 1984 Aug; 43(2):479-86. PubMed ID: 6330301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human plasma inhibitors of platelet serotonin uptake and imipramine receptor binding: extraction and heterogeneity.
    Brusov OS; Fomenko AM; Katasonov AB
    Biol Psychiatry; 1985 Mar; 20(3):235-44. PubMed ID: 2983787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between [3H]imipramine binding sites and uptake of serotonin in control, depressed and schizophrenic patients.
    Wood PL; Suranyi-Cadotte BE; Nair NP; LaFaille F; Schwartz G
    Neuropharmacology; 1983 Oct; 22(10):1211-4. PubMed ID: 6316192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered platelet 3H-imipramine binding in schizo-affective and depressive disorders.
    Suranyi-Cadotte BE; Wood PL; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Aug; 18(8):923-7. PubMed ID: 6311293
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between 3H-imipramine binding, 14C-serotonin uptake, and the surface area of blood platelets.
    Demet EM; Chicz-Demet A; Shaffer E; Ocariz J
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):289-96. PubMed ID: 2163060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal platelet 5-hydroxytryptamine uptake and imipramine binding in postnatal dysphoria.
    Hannah P; Adams D; Glover V; Sandler M
    J Psychiatr Res; 1992 Jan; 26(1):69-75. PubMed ID: 1313874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of imipramine platelet binding sites as a biological marker of endogenous depression. A World Health Organization Collaborative Study.
    Pharmacopsychiatry; 1990 May; 23(3):113-7. PubMed ID: 2165264
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet 3H-imipramine binding and red blood cell choline in affective disorders: indications of heterogeneous pathogenesis.
    Wood PL; Suranyi-Cadotte B; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Jun; 18(6):715-9. PubMed ID: 6307404
    [No Abstract]   [Full Text] [Related]  

  • 20. Circadian variation of platelet 3H-imipramine binding, platelet serotonin content, and plasma cortisol in healthy volunteers.
    Montero D; Ofori-Adjei D; Wägner A
    Biol Psychiatry; 1989 Dec; 26(8):794-804. PubMed ID: 2556189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.